Article Details
Retrieved on: 2024-02-01 17:22:11
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company is open to acquisitions of up to $15 billion, company CEO Rob Davis said Thursday on a fourth quarter earnings call. Published Feb.
Article found on: www.biopharmadive.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here